| Literature DB >> 34261433 |
Ziyi Zhao1, Chenxi Li1, Fei Tong2, Jingkuang Deng1, Guofu Huang3, Yi Sang4.
Abstract
Characterized by multiple complex mutations, including activation by oncogenes and inhibition by tumor suppressors, cancer is one of the leading causes of death. Application of CRISPR-Cas9 gene-editing technology in cancer research has aroused great interest, promoting the exploration of the molecular mechanism of cancer progression and development of precise therapy. CRISPR-Cas9 gene-editing technology provides a solid basis for identifying driver and passenger mutations in cancer genomes, which is of great value in genetic screening and for developing cancer models and treatments. This article reviews the current applications of CRISPR-Cas9 gene-editing technology in various cancer studies, the challenges faced, and the existing solutions, highlighting the potential of this technology for cancer treatment.Entities:
Keywords: CRISPR; Cancer; Cancer treatment; Cas9; High throughput screening
Year: 2021 PMID: 34261433 DOI: 10.1186/s12575-021-00151-x
Source DB: PubMed Journal: Biol Proced Online ISSN: 1480-9222 Impact factor: 3.244